SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
204 hedge funds and large institutions have $2.39B invested in Sage Therapeutics in 2022 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 57 increasing their positions, 73 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 199 → 204 (+5)
1.05% less ownership
Funds ownership: 87.86% → 86.8% (-1.1%)
22% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 73
Holders
204
Holding in Top 10
3
Calls
$22M
Puts
$6.63M
Top Buyers
| 1 | +$473M | |
| 2 | +$26.7M | |
| 3 | +$22.3M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.92M |
| 5 |
Morgan Stanley
New York
|
+$6.21M |
Top Sellers
| 1 | -$32.2M | |
| 2 | -$31.4M | |
| 3 | -$9.27M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$8.67M |
| 5 |
Goldman Sachs
New York
|
-$6.31M |